Copyright Reports & Markets. All rights reserved.

Global and Japan Hospital-Acquired Disease Testing Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Hospital-Acquired Disease Testing Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 UTI Testing
    • 1.2.3 SSI Testing
    • 1.2.4 Pneumococcal Infections Testing
    • 1.2.5 Bloodstream Infections Testing
    • 1.2.6 MRSA Testing
  • 1.3 Market by Application
    • 1.3.1 Global Hospital-Acquired Disease Testing Market Share by Application: 2020 VS 2026
    • 1.3.2 Small and Medium Sized Hospitals
    • 1.3.3 Large Sized Hospitals
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Hospital-Acquired Disease Testing Market Perspective (2015-2026)
  • 2.2 Global Hospital-Acquired Disease Testing Growth Trends by Regions
    • 2.2.1 Hospital-Acquired Disease Testing Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Hospital-Acquired Disease Testing Historic Market Share by Regions (2015-2020)
    • 2.2.3 Hospital-Acquired Disease Testing Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Hospital-Acquired Disease Testing Players by Market Size
    • 3.1.1 Global Top Hospital-Acquired Disease Testing Players by Revenue (2015-2020)
    • 3.1.2 Global Hospital-Acquired Disease Testing Revenue Market Share by Players (2015-2020)
  • 3.2 Global Hospital-Acquired Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Hospital-Acquired Disease Testing Revenue
  • 3.4 Global Hospital-Acquired Disease Testing Market Concentration Ratio
    • 3.4.1 Global Hospital-Acquired Disease Testing Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Hospital-Acquired Disease Testing Revenue in 2019
  • 3.5 Key Players Hospital-Acquired Disease Testing Area Served
  • 3.6 Key Players Hospital-Acquired Disease Testing Product Solution and Service
  • 3.7 Date of Enter into Hospital-Acquired Disease Testing Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Hospital-Acquired Disease Testing Breakdown Data by Type (2015-2026)

  • 4.1 Global Hospital-Acquired Disease Testing Historic Market Size by Type (2015-2020)
  • 4.2 Global Hospital-Acquired Disease Testing Forecasted Market Size by Type (2021-2026)

5 Hospital-Acquired Disease Testing Breakdown Data by Application (2015-2026)

  • 5.1 Global Hospital-Acquired Disease Testing Historic Market Size by Application (2015-2020)
  • 5.2 Global Hospital-Acquired Disease Testing Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Hospital-Acquired Disease Testing Market Size (2015-2026)
  • 6.2 North America Hospital-Acquired Disease Testing Market Size by Type (2015-2020)
  • 6.3 North America Hospital-Acquired Disease Testing Market Size by Application (2015-2020)
  • 6.4 North America Hospital-Acquired Disease Testing Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Hospital-Acquired Disease Testing Market Size (2015-2026)
  • 7.2 Europe Hospital-Acquired Disease Testing Market Size by Type (2015-2020)
  • 7.3 Europe Hospital-Acquired Disease Testing Market Size by Application (2015-2020)
  • 7.4 Europe Hospital-Acquired Disease Testing Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Hospital-Acquired Disease Testing Market Size (2015-2026)
  • 8.2 China Hospital-Acquired Disease Testing Market Size by Type (2015-2020)
  • 8.3 China Hospital-Acquired Disease Testing Market Size by Application (2015-2020)
  • 8.4 China Hospital-Acquired Disease Testing Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Hospital-Acquired Disease Testing Market Size (2015-2026)
  • 9.2 Japan Hospital-Acquired Disease Testing Market Size by Type (2015-2020)
  • 9.3 Japan Hospital-Acquired Disease Testing Market Size by Application (2015-2020)
  • 9.4 Japan Hospital-Acquired Disease Testing Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Hospital-Acquired Disease Testing Market Size (2015-2026)
  • 10.2 Southeast Asia Hospital-Acquired Disease Testing Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Hospital-Acquired Disease Testing Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Hospital-Acquired Disease Testing Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Diatherix Laboratories
    • 11.1.1 Diatherix Laboratories Company Details
    • 11.1.2 Diatherix Laboratories Business Overview
    • 11.1.3 Diatherix Laboratories Hospital-Acquired Disease Testing Introduction
    • 11.1.4 Diatherix Laboratories Revenue in Hospital-Acquired Disease Testing Business (2015-2020))
    • 11.1.5 Diatherix Laboratories Recent Development
  • 11.2 Gen-Probe
    • 11.2.1 Gen-Probe Company Details
    • 11.2.2 Gen-Probe Business Overview
    • 11.2.3 Gen-Probe Hospital-Acquired Disease Testing Introduction
    • 11.2.4 Gen-Probe Revenue in Hospital-Acquired Disease Testing Business (2015-2020)
    • 11.2.5 Gen-Probe Recent Development
  • 11.3 Qiagen
    • 11.3.1 Qiagen Company Details
    • 11.3.2 Qiagen Business Overview
    • 11.3.3 Qiagen Hospital-Acquired Disease Testing Introduction
    • 11.3.4 Qiagen Revenue in Hospital-Acquired Disease Testing Business (2015-2020)
    • 11.3.5 Qiagen Recent Development
  • 11.4 F. Hoffmann-La Roche
    • 11.4.1 F. Hoffmann-La Roche Company Details
    • 11.4.2 F. Hoffmann-La Roche Business Overview
    • 11.4.3 F. Hoffmann-La Roche Hospital-Acquired Disease Testing Introduction
    • 11.4.4 F. Hoffmann-La Roche Revenue in Hospital-Acquired Disease Testing Business (2015-2020)
    • 11.4.5 F. Hoffmann-La Roche Recent Development
  • 11.5 Cepheid
    • 11.5.1 Cepheid Company Details
    • 11.5.2 Cepheid Business Overview
    • 11.5.3 Cepheid Hospital-Acquired Disease Testing Introduction
    • 11.5.4 Cepheid Revenue in Hospital-Acquired Disease Testing Business (2015-2020)
    • 11.5.5 Cepheid Recent Development
  • 11.6 Life Technologies Corporation
    • 11.6.1 Life Technologies Corporation Company Details
    • 11.6.2 Life Technologies Corporation Business Overview
    • 11.6.3 Life Technologies Corporation Hospital-Acquired Disease Testing Introduction
    • 11.6.4 Life Technologies Corporation Revenue in Hospital-Acquired Disease Testing Business (2015-2020)
    • 11.6.5 Life Technologies Corporation Recent Development
  • 11.7 Meridian Biosciences
    • 11.7.1 Meridian Biosciences Company Details
    • 11.7.2 Meridian Biosciences Business Overview
    • 11.7.3 Meridian Biosciences Hospital-Acquired Disease Testing Introduction
    • 11.7.4 Meridian Biosciences Revenue in Hospital-Acquired Disease Testing Business (2015-2020)
    • 11.7.5 Meridian Biosciences Recent Development
  • 11.8 Cantel Medical Corporation
    • 11.8.1 Cantel Medical Corporation Company Details
    • 11.8.2 Cantel Medical Corporation Business Overview
    • 11.8.3 Cantel Medical Corporation Hospital-Acquired Disease Testing Introduction
    • 11.8.4 Cantel Medical Corporation Revenue in Hospital-Acquired Disease Testing Business (2015-2020)
    • 11.8.5 Cantel Medical Corporation Recent Development
  • 11.9 Nordion
    • 11.9.1 Nordion Company Details
    • 11.9.2 Nordion Business Overview
    • 11.9.3 Nordion Hospital-Acquired Disease Testing Introduction
    • 11.9.4 Nordion Revenue in Hospital-Acquired Disease Testing Business (2015-2020)
    • 11.9.5 Nordion Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Hospital-Acquired Disease Testing Scope and Market Size
    Hospital-Acquired Disease Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hospital-Acquired Disease Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    UTI Testing
    SSI Testing
    Pneumococcal Infections Testing
    Bloodstream Infections Testing
    MRSA Testing

    Market segment by Application, split into
    Small and Medium Sized Hospitals
    Large Sized Hospitals

    Based on regional and country-level analysis, the Hospital-Acquired Disease Testing market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Hospital-Acquired Disease Testing market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Diatherix Laboratories
    Gen-Probe
    Qiagen
    F. Hoffmann-La Roche
    Cepheid
    Life Technologies Corporation
    Meridian Biosciences
    Cantel Medical Corporation
    Nordion

    Buy now